Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

773
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
773
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

12
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
12
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

880
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
880
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

15
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

570
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
570

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expanding awareness of potentially life‑threatening adverse effects of metformin.

Critical care (London, England)·2026
Same author

Letter to the editor: The impact of ketamine on ICU mortality in patients with sepsis: A retrospective cohort study.

Journal of critical care·2026
Same author

Potential Confounding Effects of Continuous Kidney Replacement Therapy on S100-β Levels in Dexmedetomidine-Treated Septic Patients: A Methodological Consideration.

Critical care medicine·2026
Same author

Adjunctive Midodrine Therapy for Vasopressor-Dependent Shock in the ICU: A Closer Examination of Serious Adverse Effects.

Critical care medicine·2026
Same author

Letter to the editor: A multicenter survey of critical care clinicians' attitudes and practices on guidance during percutaneous dilatational tracheostomy.

Journal of critical care·2026
Same author

Correction: Xuebijing as a potential therapeutic option for septic shock: the need for rigorous evaluation of life-threatening adverse effects.

Critical care (London, England)·2026

Related Experiment Video

Updated: Jul 28, 2025

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

722

Anticoagulation Prophylaxis in Extracorporeal Adsorption Techniques.

Patrick M Honore1, Sydney Blackman2, Ibrahim Bousbiat2

  • 1CHU UCL Godinne Namur, UCL Louvain Medical Shool, Campus Godinne, Namur, Belgium.

Contributions to Nephrology
|June 1, 2023
PubMed
Summary

Regional citrate anticoagulation (RCA) appears more effective than unfractionated heparin (UFH) for adsorption techniques in continuous renal replacement therapy (CKRT). Further studies are needed to confirm optimal anticoagulation strategies for various adsorptive therapies.

More Related Videos

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

476
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.8K

Related Experiment Videos

Last Updated: Jul 28, 2025

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

722
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

476
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.8K

Area of Science:

  • Nephrology
  • Critical Care Medicine
  • Biomaterials Science

Background:

  • Continuous renal replacement therapy (CKRT) often requires anticoagulation to prevent circuit clotting.
  • Adsorption techniques in CKRT utilize specialized membranes and sorbents, necessitating distinct anticoagulation strategies compared to nonadsorptive therapies.
  • Common anticoagulants include regional citrate anticoagulation (RCA) and unfractionated heparin (UFH).

Purpose of the Study:

  • To review and compare anticoagulation treatments specifically for adsorption techniques used in CKRT.
  • To evaluate the efficacy of different anticoagulation modalities, particularly RCA and UFH, with various adsorptive membranes and sorbents.
  • To discuss anticoagulation prophylaxis for emerging and specific adsorption techniques in CKRT.

Main Methods:

  • Review of current literature and clinical practices regarding anticoagulation in CKRT with adsorption.
  • Comparison of RCA and UFH efficacy based on available data for nonselective and selective adsorptive membranes (e.g., AN69ST, polymethylmethacrylate, AN69-oXiris).
  • Discussion of anticoagulation for nonselective adsorptive sorbents (e.g., CytoSorb, Jafron HA) and selective adsorptive sorbents (e.g., polymyxin-B hemoperfusion).

Main Results:

  • Regional citrate anticoagulation (RCA) demonstrates superior efficacy compared to unfractionated heparin (UFH) in many adsorption techniques within CKRT.
  • While RCA and UFH are common, large comparative studies are lacking for many adsorptive filter techniques.
  • Evidence suggests RCA and UFH are appropriate for selective adsorptive sorbents, but require further randomized controlled trials for confirmation.

Conclusions:

  • Regional citrate anticoagulation (RCA) is often the preferred modality for anticoagulation in CKRT adsorption techniques due to perceived superior efficacy over unfractionated heparin (UFH).
  • Anticoagulation strategies must be tailored to the specific adsorptive membrane or sorbent used.
  • Further high-quality research, including randomized controlled trials, is essential to establish definitive evidence-based guidelines for anticoagulation in CKRT adsorption therapies.